The Latest Breaking News from Covid-19

The Food and Drug Administration’s panel of independent vaccine experts recently voted 19 to 2 to recommend a new batch of COVID-19 booster shots targeting the omicron variant this fall. The news, announced Tuesday, June 28, could have a big impact on the share prices of vaccine makers.

Exclusive: 16% plan to look for new jobs according to survey of 348 Ambulance Victoria staff

Here's a roundup of top developments in the biotech space over the last 24 hours:

InflaRx N.V. (NASDAQ:IFRX) provided a development update for its monoclonal anti-C5a antibody, vilobelimab, in pyoderma gangrenosum (PG) and severe COVID-19. The FDA and the European Medicines Agency (EMA) have granted orphan drug designation to vilobelimab for PG. PG is a rare condition that causes large, painful sores (ulcers) to develop on the skin.…

Jo Maugham, of the Good Law Project, says people want to know why laws seem to apply to them but not to Boris Johnson

Anthony Fauci, the chief medical adviser to President Joe Biden, suffered a rebound of COVID-19 symptoms after taking Pfizer Inc.’s antiviral Paxlovid.

Medical experts warn that repeated COVID-19 infections are getting more likely as the pandemic drags on and the coronavirus evolves

LOS ANGELES — With tens of thousands of new coronavirus cases being reported in California each week, it might seem inevitable that everyone will get infected at some point.

Airlines have been told to cut services now to avoid chaos later